Intervention With A Novel, Erythropoietin-derived Peptide Protects Against Neuroglial And Vascular Degeneration During Diabetic Retinopathy
Alan W. Stitt(Queen's University Belfast), Anthony Cerami(Araim Pharmaceuticals (United States)), Michael Brines(Northwell Health), Liza Colhoun(Queen's University Belfast), R. Hamilton(Queen's University Belfast), Tom A. Gardiner(National Physical Laboratory), Carmel McVicar(Queen's University Belfast)
Investigative Ophthalmology & Visual Science
April 22, 2011
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
|JCI Insight|2017|1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k